Literature DB >> 23908463

Ikaros is required to survive positive selection and to maintain clonal diversity during T-cell development in the thymus.

Kevin W Tinsley1, Changwan Hong, Megan A Luckey, Joo-Young Park, Grace Y Kim, Hee-Won Yoon, Hilary R Keller, Andrew J Sacks, Lionel Feigenbaum, Jung-Hyun Park.   

Abstract

The zinc-finger protein Ikaros is a key player in T-cell development and a potent tumor suppressor in thymocytes. To understand the molecular basis of its function, we disabled Ikaros activity in vivo using a dominant negative Ikaros transgene (DN-IkTg). In DN-IkTg mice, T-cell development was severely suppressed, and positively selected thymocytes clonally expanded, resulting in a small thymus with a heavily skewed T-cell receptor (TCR) repertoire. Notably, DN-IkTg induced vigorous proliferation concomitant to downregulation of antiapoptotic factor expression such as Bcl2. Ikaros activity was required during positive selection, and specifically at the CD4(+)CD8(lo) intermediate stage of thymocyte differentiation, where it prevented persistent TCR signals from inducing aberrant proliferation and expansion. In particular, DN-IkTg induced the accumulation of CD4 single-positive (SP) thymocytes with a developmentally transitional phenotype, and it imposed a developmental arrest accompanied by massive apoptosis. Thus, we identified an in vivo requirement for Ikaros function, which is to suppress the proliferative potential of persistent TCR signals and to promote the survival and differentiation of positively selected thymocytes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23908463      PMCID: PMC3790506          DOI: 10.1182/blood-2012-12-472076

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  49 in total

1.  Coreceptor reversal in the thymus: signaled CD4+8+ thymocytes initially terminate CD8 transcription even when differentiating into CD8+ T cells.

Authors:  E Brugnera; A Bhandoola; R Cibotti; Q Yu; T I Guinter; Y Yamashita; S O Sharrow; A Singer
Journal:  Immunity       Date:  2000-07       Impact factor: 31.745

2.  Eos and pegasus, two members of the Ikaros family of proteins with distinct DNA binding activities.

Authors:  J Perdomo; M Holmes; B Chong; M Crossley
Journal:  J Biol Chem       Date:  2000-12-08       Impact factor: 5.157

3.  Kinetics of mature T-cell development in the thymus.

Authors:  M Egerton; R Scollay; K Shortman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

4.  Selective development of CD4+ T cells in transgenic mice expressing a class II MHC-restricted antigen receptor.

Authors:  J Kaye; M L Hsu; M E Sauron; S C Jameson; N R Gascoigne; S M Hedrick
Journal:  Nature       Date:  1989-10-26       Impact factor: 49.962

5.  CD8 coreceptor extinction in signaled CD4(+)CD8(+) thymocytes: coordinate roles for both transcriptional and posttranscriptional regulatory mechanisms in developing thymocytes.

Authors:  R Cibotti; A Bhandoola; T I Guinter; S O Sharrow; A Singer
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

6.  Detection of different Ikaros isoforms in human leukaemias using real-time quantitative polymerase chain reaction.

Authors:  S Olivero; C Maroc; E Beillard; J Gabert; W Nietfeld; C Chabannon; C Tonnelle
Journal:  Br J Haematol       Date:  2000-09       Impact factor: 6.998

7.  The kinetics of immature murine thymocyte development in vivo.

Authors:  M Egerton; K Shortman; R Scollay
Journal:  Int Immunol       Date:  1990       Impact factor: 4.823

8.  Expression of the Ikaros gene family in childhood acute lymphoblastic leukaemia.

Authors:  Mami Takanashi; Tomohito Yagi; Toshihiko Imamura; Yasuhiro Tabata; Akira Morimoto; Shigeyoshi Hibi; Eiichi Ishii; Shinsaku Imashuku
Journal:  Br J Haematol       Date:  2002-06       Impact factor: 6.998

9.  Ikaros null mice display defects in T cell selection and CD4 versus CD8 lineage decisions.

Authors:  Julie A Urban; Susan Winandy
Journal:  J Immunol       Date:  2004-10-01       Impact factor: 5.422

10.  Subpopulations of mature murine thymocytes: properties of CD4-CD8+ and CD4+CD8- thymocytes lacking the heat-stable antigen.

Authors:  A Wilson; L M Day; R Scollay; K Shortman
Journal:  Cell Immunol       Date:  1988-12       Impact factor: 4.868

View more
  6 in total

1.  Ikaros' suspended flight in the thymus.

Authors:  Naomi Taylor; Valérie S Zimmermann
Journal:  Blood       Date:  2013-10-03       Impact factor: 22.113

2.  Expression patterns of Ikaros family members during positive selection and lineage commitment of human thymocytes.

Authors:  Julie L Mitchell; Amara Seng; Thomas M Yankee
Journal:  Immunology       Date:  2016-09-20       Impact factor: 7.397

3.  TCF-1 and HEB cooperate to establish the epigenetic and transcription profiles of CD4+CD8+ thymocytes.

Authors:  Akinola Olumide Emmanuel; Stephen Arnovitz; Leila Haghi; Priya S Mathur; Soumi Mondal; Jasmin Quandt; Michael K Okoreeh; Mark Maienschein-Cline; Khashayarsha Khazaie; Marei Dose; Fotini Gounari
Journal:  Nat Immunol       Date:  2018-11-12       Impact factor: 25.606

4.  GFI1 Cooperates with IKZF1/IKAROS to Activate Gene Expression in T-cell Acute Lymphoblastic Leukemia.

Authors:  Wenxiang Sun; Jingtao Guo; David McClellan; Alexandra Poeschla; Diana Bareyan; Mattie J Casey; Bradley R Cairns; Dean Tantin; Michael E Engel
Journal:  Mol Cancer Res       Date:  2022-04-01       Impact factor: 6.333

5.  An in vivo screen of noncoding loci reveals that Daedalus is a gatekeeper of an Ikaros-dependent checkpoint during haematopoiesis.

Authors:  Christian C D Harman; Will Bailis; Jun Zhao; Louisa Hill; Rihao Qu; Ruaidhrí P Jackson; Justin A Shyer; Holly R Steach; Yuval Kluger; Loyal A Goff; John L Rinn; Adam Williams; Jorge Henao-Mejia; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-19       Impact factor: 12.779

6.  Murine pancreatic adenocarcinoma reduces Ikaros expression and disrupts T cell homeostasis.

Authors:  Nadine Nelson; Shengyan Xiang; Xiaohong Zhang; Danielle Gilvary; Julie Djeu; Kazim Husain; Mokenge Malafa; Nasreen Vohra; Shari Pilon-Thomas; Tomar Ghansah
Journal:  PLoS One       Date:  2015-01-28       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.